Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy

Noboru Kitamura, Hitomi Kobayashi, Yosuke Nagasawa, Kaita Sugiyama, Hiroshi Tsuzuki, Yutaka Tanikawa, Natsumi Ikumi, Yuito Okada, Yasuo Takahashi, Satoshi Asai, Naoto Tamura, Michihiro Ogasawara, Toshio Kawamoto, Ryohei Kuwatsuru, Hiromichi Tamaki, Genki Kidoguchi, Mutsuto Tateishi, Makiko Kimura, Yuichi Mochida, Kengo HariganeTakayuki Shimazaki, Takao Koike, Kazuhide Tanimura, Hiroshi Kataoka, Koichi Amano, Hidekata Yasuoka, Masami Takei

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science